|
|
|
|
| LEADER |
02980nam a22005055i 4500 |
| 001 |
978-1-60761-262-9 |
| 003 |
DE-He213 |
| 005 |
20151103122418.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100907s2011 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781607612629
|9 978-1-60761-262-9
|
| 024 |
7 |
|
|a 10.1007/978-1-60761-262-9
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RB1-214
|
| 072 |
|
7 |
|a MMF
|2 bicssc
|
| 072 |
|
7 |
|a MED067000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07
|2 23
|
| 245 |
1 |
0 |
|a Hematopathology
|h [electronic resource] :
|b Genomic Mechanisms of Neoplastic Diseases /
|c edited by Domnita Crisan.
|
| 264 |
|
1 |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana Press,
|c 2011.
|
| 300 |
|
|
|a XII, 360 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Molecular and Translational Medicine
|
| 505 |
0 |
|
|a Chapter 1: Molecular techniques used in Hematopathology -- Chapter 2: Cytogenetics techniques used in Hematopathology -- Chapter 3: The molecular component of the new WHO classification of hematologic malignancies -- Chapter 4: Molecular pathology of pediatric acute leukemias -- Chapter 5: Molecular pathology of adult acute leukemias -- Chapter 6: Molecular pathology of lymphomas -- Chapter 7: Molecular pathology of chronic myeloproliferative neoplasms -- Chapter 8: Molecular pathology of CLL -- Chapter 9: Targeted therapy in hematologic malignancies -- Chapter 10: MicroRNAs in hematologic malignancies.
|
| 520 |
|
|
|a Hematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Hematology.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 650 |
2 |
4 |
|a Hematology.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Crisan, Domnita.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781607612612
|
| 830 |
|
0 |
|a Molecular and Translational Medicine
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-60761-262-9
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
